Maria D. Chatzidaki
Papers
1
Total Citations
17
H-Index
1
About
Maria D. Chatzidaki is a researcher whose work bridges clinical pharmacology and molecular diagnostics, with a primary focus on pharmacogenomics and personalized medicine. Her key research areas include drug metabolism, genetic polymorphisms, and therapeutic drug monitoring, particularly in the context of proton pump inhibitors. Her most notable contribution is a 2016 study examining how CYP2C19 genetic variants influence omeprazole pharmacokinetics, employing validated LC–MS/MS and Real-Time PCR methods to establish a direct link between genotype and drug exposure. This work, cited 17 times, provides critical insights for optimizing dosing strategies in diverse populations, highlighting the clinical relevance of pharmacogenetic testing. Chatzidaki’s research underscores the importance of integrating analytical chemistry with genetic analysis to advance precision therapeutics, offering a model for translating laboratory findings into actionable clinical guidelines. Her contributions are valuable for students and researchers interested in the intersection of genetics, drug metabolism, and evidence-based dosing.
Research Focus
Key Achievements
Top Papers
- 1